Journal of the American College of Certified Wound Specialists
Volume 3, Issue 2 , Pages 26-32 , June 2011

Correction of Hypoxia, a Critical Element for Wound Bed Preparation Guidelines: TIMEO2 Principle of Wound Bed Preparation

  • Jayesh B. Shah, MD, FACCWS

      Affiliations

    • South Texas Wound Associates, PA, San Antonio, TX, USA
    • Southwest Center for Wound Care and Hyperbaric Medicine, Southwest General Hospital, San Antonio, TX, USA
    • The Wound Healing Center at Northeast Baptist Hospital, San Antonio, TX, USA
    • Corresponding Author InformationCorresponding author.

References 

  1. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systemic approach to wound management. Wound Repair Regen. 2003;11:S1–S28
  2. Lazarus GS, Cooper DM, Knighton DR, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Derm. 1994;130:489–493
  3. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004;187(suppl 1):65S–70S
  4. Panuncialman J, Falanga V. The science of wound bed preparation. Surg Clin North Am. 2009;89:611–626
  5. Dowsett C. Using the TIME framework in wound bed preparation. Br J Community Nurs. 2008;13:S15–S16S18, S20
  6. Hess CT. Meeting the goal: wound bed preparation. Adv Skin Wound Care. 2008;21:344
  7. Attinger CE, Janis JE, Steinberg J, Schwartz J, Al-Attar A, Couch K. Clinical approach to wounds: débridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117(suppl 7):72S–109S
  8. Woo K, Ayello EA, Sibbald RG. The edge effect: current therapeutic options to advance the wound edge. Adv Skin Wound Care. 2007;20:99–117
  9. Waugh HV, Sherratt JA. Modeling the effects of treating diabetic wounds with engineered skin substitutes. Wound Repair Regen. 2007;15:556–565
  10. Falanga V, Saap LJ, Ozonoff A. Wound bed score and its correlation with healing of chronic wounds. Dermatol Ther. 2006;19:383–390
  11. Hopf HW, Rollins MD. Wounds: an overview of the role of oxygen. Antioxid Redox Signal. 2007;9:1183–1192
  12. Mader JT, Adams KR, Sulton TE. Infectious diseases: pathophysiology and mechanisms of hyperbaric oxygen. J Hyperbaric Med. 1987;2:133–140
  13. Adams KR, Mader JT. Aminoglycoside potentiation with adjunctive hyperbaric oxygen therapy in experimental Pseudomonas aeruginosa osteomyelitis. Undersea Hyperbaric Medical Society Annual Scientific Meeting, 1987:abstract 70.
  14. Mader JT. Phagocytic killing and hyperbaric oxygen: antibacterial mechanisms. HBO Rev. 1981;2:37–49
  15. Hart GB, Lamb RC, Strauss MB. Gas gangrene. J Trauma. 1983;23:991–1000
  16. Hunt TK, Pai MP. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet. 1972;135:561–567
  17. Hunt TK, Twomey P, Zederfeldt B, Dunphy JE. Respiratory gas tension and pH in healing wounds. Am J Surg. 1967;114:302–307
  18. Niinikoski J. Effect of oxygen supply on wound healing and formation of experimental granulation tissue. Acta Physiol Scand. 1969;334:1–72
  19. Hopf HW, Hunt TK, West JM, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg. 1997;132:997–1004
  20. Sheffield PJ. Tissue oxygen measurements with respect to soft-tissue wound healing with normobaric and hyperbaric oxygen. HBO Rev. 1985;6:18–46
  21. Sheffield PJ, Workman WT. Noninvasive tissue oxygen measurements in patients administered normobaric and hyperbaric oxygen by mask. HBO Rev. 1985;6:47–62
  22. Sheffield P. Tissue oxygen tensions. In:  Davis JC,  Hunt TK editor. Problem Wounds: The Role of Oxygen. New York, NY: Elsevier; 1988;p. 17–51
  23. Knighton D, Silver I, Hunt TK. Regulation of wound healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90:262–270
  24. Knighton DR, Oredsson S, Banda M, Hunt TK. Regulation of repair: hypoxic control of macrophage mediated angiogenesis. In:  Hunt TK,  Heppenstall RB,  Pine E,  Rovee D editor. Soft and Hard Tissue Repair. New York, NY: Praeger; 1984;p. 41–49
  25. La Van FB, Hunt TK. Oxygen and wound healing. Clin Plast Surg. 1990;170:463–472
  26. Hopf HW, Gibson JJ, Angeles AP, et al. Hyperoxia and angiogenesis. Wound Repair Regen. 2005;13:558–564
  27. Robson MC, Stenberg BD, Heggers JP. Wound healing alterations caused by infection. Clin Plast Surg. 1990;17:485–492
  28. Greif R, Akça O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. New Engl J Med. 2000;342:161–167
  29. Chang N, Mathes SJ. Comparison of the effect of bacterial inoculation in musculocutaneous and random-pattern flaps. Plast Reconstr Surg. 1982;70:1–10
  30. Rabkin J, Hunt TK. Infection and oxygen. In:  Davis JC,  Hunt TK editor. Problem Wounds: The Role of Oxygen. New York, NY: Elsevier; 1988;p. 1–16
  31. Hunt TK. The physiology of wound healing. Ann Emerg Med. 1988;17:1265–1273
  32. Fife CE, Smart DR, Sheffield PJ, Hopf HW, Hawkins G, Clarke D. Transcutaneous oximetry in clinical practice: consensus statements from an expert panel based on evidence. Undersea Hyperb Med. 2009;36:43–53
  33. Pecoraro RE, Ahronio JH, Boyko EJ, Stensel VL. Chronology and determinants of tissue repair in diabetes lower extremity ulcers. Diabetes. 1991;40:1305–1313
  34. Fife CE, Buyukcakir C, Otto GH, et al. The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1144 patients. Wound Repair Regen. 2002;10:198–207
  35. Silver IA. Cellular microenvironment in healing and nonhealing wounds. In:  Hunt TK,  Heppenstall RB,  Pins E,  Rovee D editor. Soft and Hard Tissue Repair. New York, NY: Praeger; 1984;p. 50–66
  36. Sheffield PJ. Measuring tissue oxygen tension: a review. Undersea Hyperb Med. 1998;25:179–188
  37. Sheffield PJ, Buckley CJ. Transcutaneous oximetry. In:  Sheffield PJ,  Fife CE,  Smith AP editor. Wound Care Practice. Flagstaff, AZ: Best Publishing; 2004;p. 117–136
  38. Fife CE. Hyperbaric oxygen therapy applications in wound care. In:  Sheffield PJ,  Fife CE,  Smith AP editor. Wound Care Practice. Flagstaff, AZ: Best Publishing; 2004;p. 661–684
  39. Huch R, Huch A. Fetal and maternal PtcO2 monitoring. Crit Care Med. 1981;9:694–697
  40. Ravindranath T. Non-invasive monitoring in the pediatric ICU, part 1: Transcutaneous oxygen monitoring (PtcO2). Ind J Pediatr. 1990;57:169–173
  41. Serafin D, Lesesne CB, Mullen RY, Georgiadi ND. Transcutaneous Po2 monitoring for assessing viability and predicting survival of skin flaps: experimental and clinical correlations. J Microsurg. 1981;2:165–178
  42. Rooke TW. The use of transcutaneous oximetry in the noninvasive vascular laboratory. Int Angiol. 1992;11:36–40
  43. Dennhardt R, Fricke M, Mahal S, Huch A, Huch R. Transcutaneous Po2 monitoring in anaesthesia. Eur J Intens Care Med. 1976;2:29–33
  44. Wyss CR, Harrington RM, Burgess EM, Matson FA. Transcutaneous oxygen tension as a predictor of success after an amputation. J Bone Joint Surg. 1988;70:203–207
  45. Cavorsi J, Vicari F, Wirthlin DJ, et al. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen. 2006;14(2):102–109
  46. Ballard JL, Eke CC, Bunt TJ, Killeen JD. A prospective evaluation of PtcO2 measurements in management of diabetic foot problems. J Vasc Surg. 1995;22:485–492
  47. Padberg FT, Back TL, Thompson PN, Hobson RW. Transcutaneous oxygen (TcPO2) estimates probability of healing in the ischemic extremity. J Surg Res. 1996;60:365–369
  48. Snyder RJ, Kirsner RS, Warriner RA, Lavery LA, Hanft JR, Sheehan P. Consensus recommendation on advancing the standard of care for treating neuropathic foot ulcers in patients with diabetes. Ostomy Wound Manage. 2010;56(suppl 4):S1–S24
  49. Saltzman HA. Rational normobaric and hyperbaric oxygen therapy. Ann Intern Med. 1967;67:843–852
  50. Mandell G. Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun. 1974;9:337–341
  51. Mader JT, Brown GL, Guckian JC, Wells CH, Reinarz JA. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis. 1980;142:915–922
  52. Adams KR, Sutton TE, Mader JT. In vitro potentiation of tobramycin under hyperoxic conditions. Undersea Hyperbaric Medical Society Annual Scientific Meeting; 1987:abstract 69.
  53. Van Unnik AJ. Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie Leewenhoek Microbiol. 1965;31:181–186
  54. Goldman RJ. HBO for wound healing and limb salvage: a systemic review. Phys Med. Rehab. 2009;1:471–489
  55. Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010;33:998–1003
  56. American Diabetes Association. Consensus development conference on diabetic foot wound care. Diabetes Care. 1999;22:1354–1360
  57. Snyder RJ, Cardinal M, Dauphinée DM, Stavosky J. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks. Ostomy Wound Manage. 2010;56:44–50
  58. Margolis DJ, Allen-Taylor L, Hoffstad O, Berlin JA. Diabetic neuropathic foot ulcers: predicting which ones will not heal. Am J Med. 2003;115:627–631
  59. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003;26:1879–1882
  60. Warriner RA, Hopf HW. Enhancement of healing in selected problem wounds. In:  Gesell LB editors. Hyperbaric Oxygen Therapy: Indications. 12th ed. Durham, NC: Undersea and Hyperbaric Medical Society; 2008;p. 67–83
  61. Marx RE. Radiation injury to tissue. In:  Kindwall EP editors. Hyperbaric Medicine Practice. 2nd ed. Flagstaff, AZ: Best Publishing; 1999;p. 665–723
  62. Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983;41:283–288
  63. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 2006;14:680–692
  64. Kantor J, Margolis DJ. From clinical trials to clinical practice: the efficacy and prognostic value of simple wound measurements. Arch Dermatol. 1998;134:1571–1574
  65. Kantor J, Margolis DJ. A multicenter study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol. 2000;142:960–964
  66. Robson MC, Hill DP, Woodske ME, Steed DL. Wound healing trajectories as predictors of effectiveness of therapeutic agents. Arch Surg. 2000;135:773–777
  67. Skin Substitutes Consensus Development Panel. Nonoperative management of venous leg ulcers: evolving role of skin substitutes. Vasc Surg. 1999;33:197–210
  68. Falanga V, Sabolinski ML. Prognostic factors for healing of venous and diabetic ulcers. Wounds. 2000;12:42A–46A
  69. Smith AP, Bozzuto TM. Advanced therapeutics: the biochemistry and biophysical basis of wound products. In:  Sheffield PJ,  Fife CE editor. Wound Care Practice. 2nd ed. Flagstaff, AZ: Best Publishing; 2007;p. 981–1034
  70. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283–1300
  71. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg. 1995;21:71–81
  72. Brem H, Young J, Tomic-Canic M, Isaacs C, Ehrlich HP. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers. Surg Technol Int. 2003;11:23–31
  73. Falanga V, Margolis D, Alvarz O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998;134:293–300
  74. Joseph E, Hamori CA, Bergman S, Roaf C, Swan N. A prospective randomized trial of vacuum assisted closure versus standard therapy of chronic non-healing wounds. Wounds. 2000;12:60–67
  75. Fife CE. Hyperbaric oxygen therapy applications in wound care. In:  Sheffield PJ,  Fife CE editor. Wound Care Practice. 2nd ed. Flagstaff, AZ: Best Publishing; 2007;p. 947–980
  76. Shah J, Fife C, Sheffield P. Wound care certification Study Guide, Best Publishing, Chapter 31, Dr.Shah's Wound Management Guidelines.

 Conflict of interest: The author reports no conflicts of interest.

PII: S1876-4983(11)00111-1

doi: 10.1016/j.jcws.2011.09.001

Journal of the American College of Certified Wound Specialists
Volume 3, Issue 2 , Pages 26-32 , June 2011

Article Tools

* Image Usage & Resolution